| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 103.05B | 109.86B | 100.97B | 101.36B | 97.40B | 81.60B |
| Gross Profit | 14.70B | 15.72B | 14.37B | 14.11B | 13.84B | 12.17B |
| EBITDA | 4.57B | 4.96B | 4.40B | 4.47B | 4.78B | 3.69B |
| Net Income | 2.42B | 2.96B | 2.66B | 2.50B | 2.74B | 2.09B |
Balance Sheet | ||||||
| Total Assets | 60.61B | 64.89B | 63.69B | 65.13B | 64.08B | 59.15B |
| Cash, Cash Equivalents and Short-Term Investments | 9.46B | 9.72B | 8.97B | 8.23B | 6.49B | 6.05B |
| Total Debt | 1.33B | 1.47B | 1.50B | 1.73B | 5.09B | 2.87B |
| Total Liabilities | 19.77B | 20.64B | 22.84B | 26.05B | 28.46B | 25.97B |
| Stockholders Equity | 40.81B | 44.20B | 40.82B | 39.06B | 35.59B | 33.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.31B | 1.72B | 5.97B | -898.00M | -1.18B |
| Operating Cash Flow | 0.00 | 2.98B | 1.82B | 6.08B | -716.00M | -890.00M |
| Investing Cash Flow | 0.00 | -1.80B | -95.00M | -84.00M | -191.00M | -3.81B |
| Financing Cash Flow | 0.00 | -1.16B | -1.31B | -4.42B | 1.20B | 2.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥74.02B | 8.02 | ― | 2.87% | 50.78% | 26.58% | |
73 Outperform | ¥72.34B | 9.45 | 5.37% | 3.41% | -1.40% | 13.91% | |
71 Outperform | ¥544.93B | 14.85 | ― | 2.87% | 17.41% | 10.46% | |
66 Neutral | ¥613.90B | 90.12 | ― | 0.79% | 3.53% | -18.43% | |
63 Neutral | ¥35.16B | 17.69 | ― | 3.02% | 8.81% | 11.05% | |
62 Neutral | ¥95.90B | 7.40 | ― | 2.41% | 50.28% | 79.25% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |